230 studies found for:    "Adrenal Gland Diseases" [DISEASE]
Show Display Options
Rank Status Study
21 Unknown  Adrenal Function After Living Kidney Donation
Conditions: Addison Disease;   Hypoaldosteronism
Intervention: Procedure: Laparoscopic hand-assisted donor nephrectomy
22 Recruiting Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention:
23 Recruiting Evaluation of Patients With Endocrine-Related Conditions
Conditions: Adrenal Insufficiency;   Pituitary Neoplasm;   Obesity
Intervention:
24 Unknown  Kallikrein-Kinin (KKS) and Renin-Angiotensin-Aldosterone System (RAAS) in Primary Aldosteronism
Condition: Hyperaldosteronism
Intervention: Drug: captopril, Losartan (drug)
25 Completed Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease
Condition: Cushing Disease
Intervention: Drug: Pasireotide
26 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Intervention: Procedure: Adrenalectomy
27 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003
28 Unknown  Preoperative Bexarotene Treatment for Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Bexarotene
29 Unknown  Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
30 Recruiting Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: SOM230 LAR 30 mg;   Drug: SOM230 LAR 10 mg
31 Unknown  Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic Function
Condition: Cirrhosis With Ascites
Interventions: Drug: hydrocortisone;   Drug: dextrose solution 5%
32 Recruiting Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
33 Completed Adrenal Hyperplasia Among Young People With PCOS
Conditions: Adrenal Hyperplasia;   Polycystic Ovarian Syndrome;   Oligomenorrhea;   Obesity;   Hyperandrogenism
Intervention:
34 Recruiting Human Placental-Derived Stem Cell Transplantation
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis VI;   Adrenoleukodystrophy;   Niemann-Pick Disease;   Metachromatic Leukodystrophy;   Wolman Disease;   Krabbe's Disease;   Gaucher's Disease;   Fucosidosis;   Batten Disease;   Severe Aplastic Anemia;   Diamond-Blackfan Anemia;   Amegakaryocytic Thrombocytopenia;   Myelodysplastic Syndrome;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia
Intervention: Drug: Human Placental Derived Stem Cell
35 Recruiting Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
Conditions: Cushing's Syndrome;   Adrenal Incidentalomas;   Alcoholism;   Obesity
Intervention:
36 Completed Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
Condition: Primary Hyperaldosteronism
Intervention: Drug: LCI699
37 Completed Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
Conditions: Adrenal Gland Hyperfunction;   Adrenal Gland Hypofunction;   Cushing's Syndrome;   Healthy
Intervention: Drug: Ovine Corticotropin-Releasing Hormone (oCRH)
38 Recruiting Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.
Conditions: Adrenal Hyperplasia, Congenital;   21-hydroxylase Deficiency
Intervention: Other: Functional explorations
39 Unknown  Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome
Conditions: Hypocalcemia;   Hypercalcemia
Intervention:
40 Recruiting Natural History Study of Patients With Excess Androgen
Conditions: Excess Androgen;   Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years